Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation
BioCentury’s roundup of preclinical news
Genentech identifies blood as source of antitumor T cells
In a Nature article, a Genentech Inc. team reported that non-exhausted T cell clones in the blood could act as a source of antitumor T